POST-COVID Lipid Profile Alterations In Stage 3 Chronic Kidney Disease Patients
DOI:
https://doi.org/10.62480/tjms.2026.vol56.pp1-4Keywords:
Chronic kidney disease, COVID-19, lipid profile, total cholesterolAbstract
The study evaluated changes in renal functional status in patients with stage 3 chronic kidney disease (CKD) who had previously experienced COVID-19 infection. A total of 131 patients were included in the study: • Group 1 — CKD stage 3 (n=70); • Group 2 — CKD stage 3 + COVID-19 (n=61). For each patient, the lipid profile was evaluated, including: Total cholesterol (TC, mmol/L), Triglycerides (TG, mmol/L), Low-density lipoprotein cholesterol (LDL-C, mmol/L), High-density lipoprotein cholesterol (HDL-C, mmol/L) Laboratory measurements were performed at 1 month and 3 months. Data are presented as mean ± SEM. Statistical analysis was conducted using Student’s t-test or appropriate parametric tests. Significant changes over the 3-month period were indicated with an asterisk (*), p
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
